Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Cancer Letters|August 14, 2025
Anti-tumor activity of CDYL2b in prostate cancerRuicai Gu, Julia Janknecht, Sangphil Oh, et al.International Journal of Oncology|November 11, 2020
Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancerSangphil Oh, Hoogeun Song, Willard M Freeman, et al.Plos Biology|August 22, 2019
Correction: JMJD5 links CRY1 function and proteasomal degradationAnand R Saran, Diana Kalinowska, Sangphil Oh, et al.Plos Biology|December 1, 2018
JMJD5 links CRY1 function and proteasomal degradationAnand R Saran, Diana Kalinowska, Sangphil Oh, et al.Scientific Reports|June 5, 2019
Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate CancerSangphil Oh, Sook Shin, Hoogeun Song, et al.Frontiers in Oncology|March 9, 2023
Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of <i>ADAM19</i> and <i>KLF7</i>Yuan Sui, Hanlin Jiang, Collyn M Kellogg, et al.Journal of Cellular Biochemistry|December 3, 2011
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cellsTae-Dong Kim, Sook Shin, William L Berry, et al.Frontiers in Oncology|December 4, 2023
Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesisRuicai Gu, Tae-Dong Kim, Hanlin Jiang, et al.JCI Insight|October 23, 2023
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2ARuicai Gu, Tae-Dong Kim, Hoogeun Song, et al.International Journal of Clinical and Experimental Medicine|September 9, 2017
Upregulation of PSMD10 caused by the JMJD2A histone demethylaseTae-Dong Kim, Sangphil Oh, Stan A Lightfoot, et al.Pageof 4